Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase Through 14-3-3 Binding

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2003 Oct 16

PMID 14559997

Citations 94

Authors

Mei-Shya Chen

Christine E Ryan

Helen Piwnica-Worms

Affiliations

Soon will be listed here.

Abstract

The order and fidelity of cell cycle events in mammals is intimately linked to the integrity of the Chk1 kinase-Cdc25A phosphatase pathway. Chk1 phosphorylation targets Cdc25A for destruction and, as shown here, inhibits interactions between Cdc25A and its mitotic substrate cyclin B1-Cdk1. Phosphorylation of Cdc25A on serine 178 and threonine 507 facilitates 14-3-3 binding, and Chk1 phosphorylates both residues in vitro. Mutation of T507 to alanine (T507A) enhanced the biological activity of Cdc25A. Cdc25A(T507A) was more efficient in binding to cyclin B1, activating cyclin B1-Cdk1, and promoting premature entry into mitosis. We propose that the Chk1/Cdc25A/14-3-3 pathway functions to prevent cells from entering into mitosis prior to replicating their genomes to ensure the fidelity of the cell division process.

Citing Articles

Negative Charges, Not Necessary Phosphorylation, are Required for Ligand Recognition by 14-3-3 Proteins.

Kamayirese S, Hansen L, Lovas S bioRxiv. 2024; .

PMID: 39345434 PMC: 11429721. DOI: 10.1101/2024.09.16.613320.

Cryo-EM structure of the CDK2-cyclin A-CDC25A complex.

Rowland R, Korolchuk S, Salamina M, Tatum N, Ault J, Hart S Nat Commun. 2024; 15(1):6807.

PMID: 39122719 PMC: 11316097. DOI: 10.1038/s41467-024-51135-w.

The Development of CDC25A-Derived Phosphoseryl Peptides That Bind 14-3-3ε with High Affinities.

Kamayirese S, Maity S, Hansen L, Lovas S Int J Mol Sci. 2024; 25(9).

PMID: 38732131 PMC: 11084659. DOI: 10.3390/ijms25094918.

14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer.

Zhang Y, Yan M, Yu Y, Wang J, Jiao Y, Zheng M Cell Commun Signal. 2024; 22(1):72.

PMID: 38279176 PMC: 10811864. DOI: 10.1186/s12964-023-01420-w.

Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma.

Kamayirese S, Maity S, Dieckman L, Hansen L, Lovas S ACS Omega. 2024; 9(2):2719-2729.

PMID: 38250398 PMC: 10795040. DOI: 10.1021/acsomega.3c07740.

References

Wang B, Yang H, Liu Y, Jelinek T, Zhang L, Ruoslahti E . Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry. 1999; 38(38):12499-504. DOI: 10.1021/bi991353h. View

Powers E, Thompson D, He W, Yem A, Bannow C, Staples D . Identification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown. Biochem J. 2000; 347 Pt 3:653-60. PMC: 1221000. View

Heald R, McLoughlin M, McKeon F . Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell. 1993; 74(3):463-74. DOI: 10.1016/0092-8674(93)80048-j. View

Shimuta K, Nakajo N, Uto K, Hayano Y, Okazaki K, Sagata N . Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition. EMBO J. 2002; 21(14):3694-703. PMC: 125399. DOI: 10.1093/emboj/cdf357. View

Yang J, Winkler K, Yoshida M, Kornbluth S . Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J. 1999; 18(8):2174-83. PMC: 1171301. DOI: 10.1093/emboj/18.8.2174. View

Cangi M, Cukor B, Soung P, Signoretti S, Moreira Jr G, Ranashinge M . Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest. 2000; 106(6):753-61. PMC: 381390. DOI: 10.1172/JCI9174. View

Saha P, Eichbaum Q, Silberman E, Mayer B, Dutta A . p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol. 1997; 17(8):4338-45. PMC: 232287. DOI: 10.1128/MCB.17.8.4338. View

Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S . Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res. 1997; 57(12):2366-8. View

Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

10.

Galaktionov K, Lee A, Eckstein J, Draetta G, Meckler J, Loda M . CDC25 phosphatases as potential human oncogenes. Science. 1995; 269(5230):1575-7. DOI: 10.1126/science.7667636. View

11.

Bartek J, Lukas J . Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001; 490(3):117-22. DOI: 10.1016/s0014-5793(01)02114-7. View

12.

Blomberg I, Hoffmann I . Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol. 1999; 19(9):6183-94. PMC: 84557. DOI: 10.1128/MCB.19.9.6183. View

13.

Zhao H, Watkins J, Piwnica-Worms H . Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci U S A. 2002; 99(23):14795-800. PMC: 137498. DOI: 10.1073/pnas.182557299. View

14.

Bernardi R, Liebermann D, Hoffman B . Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene. 2000; 19(20):2447-54. DOI: 10.1038/sj.onc.1203564. View

15.

Parker L, Geahlen R, Piwnica-Worms H . Mechanisms of p34cdc2 regulation. Mol Cell Biol. 1993; 13(3):1675-85. PMC: 359480. DOI: 10.1128/mcb.13.3.1675-1685.1993. View

16.

Sexl V, Diehl J, Sherr C, Ashmun R, Beach D, Roussel M . A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene. 1999; 18(3):573-82. DOI: 10.1038/sj.onc.1202362. View

17.

Fauman E, Cogswell J, Lovejoy B, Rocque W, Holmes W, Montana V . Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell. 1998; 93(4):617-25. DOI: 10.1016/s0092-8674(00)81190-3. View

18.

Davezac N, Baldin V, Gabrielli B, Forrest A, Yashida M, Ducommun B . Regulation of CDC25B phosphatases subcellular localization. Oncogene. 2000; 19(18):2179-85. DOI: 10.1038/sj.onc.1203545. View

19.

REYNOLDS R, Yem A, Wolfe C, Deibel Jr M, CHIDESTER C, Watenpaugh K . Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol. 1999; 293(3):559-68. DOI: 10.1006/jmbi.1999.3168. View

20.

Zeng Y, Piwnica-Worms H . DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol Cell Biol. 1999; 19(11):7410-9. PMC: 84734. DOI: 10.1128/MCB.19.11.7410. View